Redox proteomics and amyloid β-peptide: Insights into Alzheimer disease

Cites (315)

Items 201–315 of 315

1. Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain
   H. Fai Poon, Alessandra Castegna, Susan A. Farr, Visith Thongboonkerd, Bert C. Lynn, William A. Banks, John Edward Morley, Jon B. Klein, David Allan Butterfield · 2004 · Neuroscience
2. Oxidatively Modified GST and MRP1 in Alzheimer?s Disease Brain: Implications for Accumulation of Reactive Lipid Peroxidation Products
   Rukhsana Sultana, David Allan Butterfield · 2004 · Neurochemical Research
3. Midlife vascular risk factors and the risk of Alzheimer’s disease: A systematic review and meta-analysis
   Meng, Xiang-Fei, Yu, Jin-Tai, Wang, Hui-Fu, Tan, Meng-Shan, Wang, Chong, Tan, Chen-Chen, Tan, Lan · 2014 · Journal of Alzheimer s Disease
4. Many Neuronal and Behavioral Impairments in Transgenic Mouse Models of Alzheimer's Disease Are Independent of Caspase Cleavage of the Amyloid Precursor Protein
   Harris, Julie A., Devidze, Nino, Halabisky, Brian, Lo, Iris, Thwin, Myo T., Yu, Gui-Qiu, Bredesen, Dale E., Masliah, Eliezer, Mucke, Lennart · 2010 · The Journal of Neuroscience
5. Redox-Regulated Chaperones
   Caroline Kumsta, Ursula Jakob · 2009 · Biochemistry
6. β-Amyloid Mediated Nitration of Manganese Superoxide Dismutase
   Anantharaman Muthuswamy, Jitbanjong Tangpong, Jeffrey N. Keller, Michael P. Murphy, William R. Markesbery, Kelley K. Kiningham, Daret K. St. Clair · 2006 · American Journal Of Pathology
7. Long-term treatment with antioxidants and a program of behavioral enrichment reduces age-dependent impairment in discrimination and reversal learning in beagle dogs
   Norton William Milgram, Elizabeth Head, Steven C. Zicker, Candace J Ikeda-Douglas, Heather L. Murphey, Bruce A. Muggenberg, Christina T. Siwak, P. Dwight Tapp, Stephen R. Lowry, Carl W. Cotman · 2004 · Experimental Gerontology
8. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer’s disease and Down Syndrome
   S. H. Kim, Michael Fountoulakis, Nigel J. Cairns, Gert Lübec · 2001 · Springer eBooks
9. Proteomic identification of proteins oxidized by Aβ(1–42) in synaptosomes: Implications for Alzheimer's disease
   Debra Boyd-kimball A, Alessandra Castegna, Rukhsana Sultana A, H. Fai Poon, Robin T. Petroze, Bert C. Lynn, Jon B. Klein, David Allan Butterfield · 2005 · Brain Research
10. Decreased RNA, and Increased RNA Oxidation, in Ribosomes from Early Alzheimer’s Disease
    Ding, Qunxing, Markesbery, William R., Cecarini, Valentina, Keller, Jeffrey N. · 2006 · Neurochemical Research
11. Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
    Kristin R. Wildsmith, Stephen P. Schauer, Ashley M. Smith, David P. Arnott, Yuda Zhu, Joshua Haznedar, Surinder Kaur, W. Rodney Mathews, Lee A. Honigberg · 2014 · Molecular Neurodegeneration
12. Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease
    Scott J. Webster, Adam D. Bachstetter, Linda J. Van Eldik · 2013 · Alzheimer s Research & Therapy
13. Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism
    Xiao Zhen Zhou, Pei‐Jung Lu, Gerburg M. Wulf, Kun Ping Lu · 1999 · Cellular and Molecular Life Sciences
14. Twenty years of Alzheimer’s disease‐causing mutations
    Alison Goate, John Hardy · 2011 · Journal of Neurochemistry
15. Early Amyloid Accumulation in the Hippocampus of SAMP8 Mice
    Jaume del Valle, Joaquim Duran‐Vilaregut, Gemma Manich, Gemma Casadesús, Mark A. Smith, Antoni Camins, Mercè Pallàs, Carme Pelegrı́, Jordi Vilaplana · 2010 · Journal of Alzheimer s Disease
16. A neuronal model of Alzheimer's disease: An insight into the mechanisms of oxidative stress–mediated mitochondrial injury
    Pradoldej M Sompol, Wanida Ittarat, Jitbanjong Tangpong, Yumin Chen, I E Doubinskaia, I. Batinic-Haberle, Hafiz Mohmmad Abdul, David Allan Butterfield, Daret K. St. Clair · 2008 · Neuroscience
17. The Role of Co-chaperones in Synaptic Proteostasis and Neurodegenerative Disease
    Erica L. Gorenberg, Sreeganga S. Chandra · 2017 · Frontiers in Neuroscience
18. Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: Redox proteomics analysis of human brain
    Fabio Di Domenico, Raffaella Coccia, Annalisa Cocciolo, Michael Paul Murphy, Giovanna Cenini, Elizabeth Head, David Allan Butterfield, Alessandra Giorgi, Maria Eugenia Schininà, Cesare Mancuso et al. · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
19. Blood and plasma-based proteomic biomarker research in Alzheimer's disease
    Simone Lista, Frank Faltraco, David Prvulovic, Harald Juergen Hampel · 2012 · Progress in Neurobiology
20. FAD mutant PS-1 gene-targeted mice: increased Aβ42 and Aβ deposition without APP overproduction
    Flood, D · 2002 · Neurobiology of Aging
21. Redox Proteomics Identification of Oxidatively Modified Brain Proteins in Alzheimer's Disease and Mild Cognitive Impairment: Insights into the Progression of this Dementing Disorder
    David Allan Butterfield, Rukhsana Sultana A · 2007 · Journal of Alzheimer s Disease
22. The 2013 SFRBM Discovery Award: Selected discoveries from the Butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment
    Butterfield, D. Allan · 2014 · Free Radical Biology and Medicine
23. Age-related changes in footshock avoidance acquisition and retention in senescence accelerated mouse (SAM)
    James F. Flood, John Edward Morley · 1993 · Neurobiology of Aging
24. Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer’s disease
    Sultana, Rukhsana, Perluigi, Marzia, Newman, Shelley F., Pierce, William M., Cini, Chiara, Coccia, Raffaella, Butterfield, D. Allan · 2010 · Antioxidants & Redox Signaling
25. Quantification of oxidized RNAs in Alzheimer's disease
    Shan, Xiu, Lin, Chien-liang Glenn · 2006 · Neurobiology of Aging
26. Midlife Fitness and the Development of Chronic Conditions in Later Life
    Benjamin L. Willis, Ang Gao, David S. Leonard, Laura F. DeFina, Jarett D. Berry · 2012 · Archives of Internal Medicine
27. Regulation and Expression of the Alzheimer's β/A4 Amyloid Protein Precursor in Health, Disease, and Down's Syndromea
    Konrad T. Beyreuther, Peter Pollwein, Gerd Multhaup, Ursula Mönning, GERHARD KÖNIG, Thomas Dyrks, WALTER J. SCHUBERT, Colin Louis Masters · 1993 · Annals of the New York Academy of Sciences
28. Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome
    Giovanna Cenini, Amy L.S. Dowling, Tina L. Beckett, Eugenio Barone, Cesare Mancuso, Michael Paul Murphy, Harry LeVine, Ira T. Lott, Frederick A. Schmitt, David Allan Butterfield et al. · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
29. Alzheimer's Disease and the Amyloid β-Protein
    Dominic M. Walsh, David B. Teplow · 2012 · Progress in molecular biology and translational science
30. Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer's disease: An initial assessment
    David Allan Butterfield, Anastazija Gnjec, H. Fai Poon, Alessandra Castegna, William M. Jr. Pierce, Jon B. Klein, Ralph Nigel Martins · 2006 · Journal of Alzheimer s Disease
31. Antisense directed at the Aβ region of APP decreases brain oxidative markers in aged senescence accelerated mice
    H. Fai Poon, Gururaj Joshi A, Rukhsana Sultana A, Susan A. Farr, William A. Banks, John Edward Morley, Vittorio Calabrese, David Allan Butterfield · 2004 · Brain Research
32. Hippocampal cholinergic neurostimulating peptides (HCNP)
    Kosei Ojika, Shigehisa Mitake, Naoki Tohdoh, Stanley H. Appel, Yasushi Otsuka, Eiichi Katada, Noriyuki Matsukawa · 2000 · Progress in Neurobiology
33. Increased Protein and Lipid Oxidative Damage in Mitochondria Isolated from Lymphocytes from Patients with Alzheimer's Disease: Insights into the Role of Oxidative Stress in Alzheimer's Disease and Initial Investigations into a Potential Biomarker for this Dementing Disorder
    Sultana, Rukhsana, Mecocci, Patrizia, Mangialasche, Francesca, Cecchetti, Roberta, Baglioni, Mauro, Butterfield, D. Allan · 2011 · Journal of Alzheimer's Disease
34. B- Amyloid increases neuronal susceptibility to injufy by glucose deprivation
    Agata Copani, Jae‐Young Koh, Carl W. Cotman · 1991 · Neuroreport
35. Mitotic-like Tau Phosphorylation by p25-Cdk5 Kinase Complex
    Malika Hamdane, Anne‐Véronique Sambo, Patrice Delobel, Séverine Bégard, Anne Violleau, André Delacourte, Philippe Bertrand, Jesús Bénavidès, Luc Buée · 2003 · Journal of Biological Chemistry
36. Heat Shock Proteins and Autophagy Pathways in Neuroprotection: From Molecular Bases to Pharmacological Interventions
    Botond Penke, Ferenc Bogár, Tim Crul, Miklós Sántha, Melinda E. Tóth, László Vı́gh · 2018 · International Journal of Molecular Sciences
37. Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer’s disease and Down Syndrome
    Michael Fountoulakis, Nigel J. Cairns, Gert Lübec · 1999 · Springer eBooks
38. Interactions of glutathione transferases with 4-hydroxynonenal
    Larissa M. Balogh, William M. Atkins · 2011 · Drug Metabolism Reviews
39. 14-3-3 proteins in neurodegeneration
    Petra Steinacker, Alastair Aitken, Markus Otto · 2011 · Seminars in Cell and Developmental Biology
40. Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease
    Fabio Di Domenico, Gilda Pupo, Antonella Tramutola, Alessandra Giorgi, Maria Eugenia Schininà, Raffaella Coccia, Elizabeth Head, David Allan Butterfield, Marzia Perluigi A · 2014 · Free Radical Biology and Medicine
41. Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Aβ(1-42): Implications for Alzheimer’s Disease
    Boyd-Kimball, Debra, Poon, H. Fai, Lynn, Bert C., Cai, Jian, Pierce Jr., William M., Klein, Jon B., Ferguson, Jmil, Link, Christopher D., Butterfield, D. Allan · 2006 · Neurobiology of Aging
42. Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients
    Di Domenico, Fabio, Pupo, Gilda, Giraldo, Esther, Badìa, Mari-Carmen, Monllor, Paloma, Lloret, Ana, Eugenia Schininà, Maria, Giorgi, Alessandra, Cini, Chiara, Tramutola, Antonella et al. · 2016 · Free Radical Biology and Medicine
43. Cognitive impairment in humanized APP×PS1 mice is linked to Aβ1–42 and NOX activation
    Bruce-Keller, Annadora J., Gupta, Sunita, Knight, Alecia G., Beckett, Tina L., McMullen, Jessica M., Davis, Paulina R., Murphy, M. Paul, Van Eldik, Linda J., St Clair, Daret, Keller, Jeffrey N. · 2011 · Neurobiology of Disease
44. Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma
    Han‐Ling Yu, Howard Mark Chertkow, Howard Bergman, Hyman M. Schipper · 2003 · PROTEOMICS
45. Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease
    Chun-Hau Chen, Wenzong Li, Rukhsana Sultana A, Mi‐Hyeon You, Asami Kondo, Koorosh Shahpasand, Byeong Mo Kim, Man-Li Luo, Morris Nechama, Yu‐Min Lin et al. · 2015 · Neurobiology of Disease
46. Beta/A4 proteinlike immunoreactive granular structures in the brain of senescence-accelerated mouse.
    Masaaki Takemura, Shinichi Nakamura, Ichiro Akiguchi, Masaki Ueno, Nobuyuki Oka, S Ishikawa, A Shimada, J Kimura, Tetsuro Takeda · 1993 · PubMed Central
47. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer’s disease: Insights into memory loss in MCI
    Aluise, Christopher D., Robinson, Renã A.S., Cai, Jian, Pierce, William M., Markesbery, William R., Butterfield, D. Allan · 2011 · Journal of Alzheimer's Disease
48. Aberrant molecular properties shared by familial Parkinson’s disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1
    Tomohiro Kabuta, Rieko Setsuie, Takeshi Mitsui, Aiko Kinugawa, Mikako Sakurai, Shunsuke Aoki, Kenko Uchida, Keiji Wada · 2008 · Human Molecular Genetics
49. Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease
    Christopher D. Aluise, Renã A. S. Robinson, David Allan Butterfield · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
50. The binding and phosphorylation of Thr231 is critical for Tau’s hyperphosphorylation and functional regulation by glycogen synthase kinase 3β
    Yuh‐Te Lin, Jiin‐Tsuey Cheng, Li‐Ching Liang, Chiung‐Yuan Ko, Yuk‐Keung Lo, Pei‐Jung Lu · 2007 · Journal of Neurochemistry
51. Protein homeostasis of a metastable subproteome associated with Alzheimer’s disease
    Rishika Kundra, Prajwal Ciryam, Richard I. Morimoto, Christopher Martin Dobson, Michele Vendruscolo · 2017 · Proceedings of the National Academy of Sciences
52. Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study
    Sultana, Rukhsana, Reed, Tanea, Perluigi, Marzia, Coccia, Rafaella, Pierce, William M., Butterfield, D. Allan · 2007 · Journal of Cellular and Molecular Medicine
53. Leisure-time physical activity associates with cognitive decline
    Joshua Zebadiah Willey, Hannah E. Gardener, Michelle R. Caunca, Yeseon Park Moon, Chuanhui Dong, Yuen K. Cheung, Ralph L. Sacco, Mitchell S.V. Elkind, Clinton B. Wright · 2016 · Neurology
54. Physical activity improves cognition: possible explanations
    Blanka Koščak Tivadar · 2017 · Biogerontology
55. Potential in vivo amelioration by N‐acetyl‐L‐cysteine of oxidative stress in brain in human double mutant APP/PS‐1 knock‐in mice: Toward therapeutic modulation of mild cognitive impairment
    Quan-Zhen Huang, C. Aluise, G. Joshi, R. Sultana, D. St. Clair, W. Markesbery, D. Butterfield · 2010 · Journal of Neuroscience Research
56. 14-3-3 Binds to and Mediates Phosphorylation of Microtubule-associated Tau Protein by Ser9-phosphorylated Glycogen Synthase Kinase 3β in the Brain
    Zongfei Yuan, Alka Agarwal-Mawal, Hemant K. Paudel · 2004 · Journal of Biological Chemistry
57. Aβ solubility and deposition during AD progression and in APP × PS-1 knock-in mice
    Michael Paul Murphy, Tina L. Beckett, Qunxing Ding, Ela Patel, William R. Markesbery, Daret K. St. Clair, Harry LeVine, Jeffrey N. Keller · 2007 · Neurobiology of Disease
58. Glucose, Lactate, β-Hydroxybutyrate, Acetate, GABA, and Succinate as Substrates for Synthesis of Glutamate and GABA in the Glutamine–Glutamate/GABA Cycle
    Leif Hertz, Douglas L. Rothman · 2016 · Advances in neurobiology
59. Multiplexed Proteomic Analysis of Oxidation and Concentrations of Cerebrospinal Fluid Proteins in Alzheimer Disease
    Minna A. Korolainen, Tuula A. Nyman, Paula Nyyssönen, Samuel Hartikainen, Tuula Pirttilä · 2007 · Clinical Chemistry
60. Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing
    Robert H. Pietrzak, Yen Ying Lim, David J. Ames, Karra Harrington, Carolina Restrepo, Ralph Nigel Martins, Alan Rembach, Simon Matthew Laws, Colin Louis Masters, Victor L. Villemagne et al. · 2014 · Neurobiology of Aging
61. Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies
    Pankajavalli Ramakrishnan, Dennis W. Dickson, Peter Davies · 2003 · Neurobiology of Disease
62. Decreased Expression of Hippocampal Cholinergic Neurostimulating Peptide Precursor Protein mRNA in the Hippocampus in Alzheimer Disease
    Mina Maki, Noriyuki Matsukawa, Hiroyuki Yuasa, Yasushi Otsuka, Takayuki Yamamoto, Hiroyasu Akatsu, Takashi Okamoto, Ryuzo Ueda, Kosei Ojika · 2002 · Journal of Neuropathology & Experimental Neurology
63. Oxidative Modification of Brain Proteins in Alzheimer's Disease: Perspective on Future Studies Based on Results of Redox Proteomics Studies
    Rukhsana Sultana A, David Allan Butterfield · 2012 · Journal of Alzheimer s Disease
64. Preclinical Alzheimer disease: Brain oxidative stress, Aβ peptide and proteomics
    Christopher D. Aluise, Renã A. Sowell, Tina L. Beckett, Michael Paul Murphy, Jian Cai, William M. Jr. Pierce, William R. Markesbery, David Allan Butterfield · 2010 · Neurobiology of Disease
65. Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age
    Hafiz Mohmmad Abdul, Rukhsana Sultana A, Daret K. St. Clair, William R. Markesbery, David Allan Butterfield · 2008 · Free Radical Biology and Medicine
66. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET.
    Satoshi Yamaguchi, Kenichi Meguro, M Itoh, C. Hayasaka, Masako Shimada, Hideki Yamazaki, Atsushi Yamadori · 1997 · Journal of Neurology Neurosurgery & Psychiatry
67. Proteomic identification of less oxidized brain proteins in aged senescence-accelerated mice following administration of antisense oligonucleotide directed at the Aβ region of amyloid precursor protein
    H. Fai Poon, Susan A. Farr, William A. Banks, William M. Jr. Pierce, Jon B. Klein, John Edward Morley, David Allan Butterfield · 2005 · Molecular Brain Research
68. Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer’s disease mice at its earliest pathological stage
    Shen, Liming, Chen, Cheng, Yang, Aochu, Chen, Youjiao, Liu, Qiong, Ni, Jiazuan · 2015 · Journal of Proteomics
69. Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer’s Disease: Comparison and Contrast with Microtubule-Associated Protein Tau
    Kenneth Hensley, Petri Kursula · 2016 · Journal of Alzheimer s Disease
70. Integration between Glycolysis and Glutamate-Glutamine Cycle Flux May Explain Preferential Glycolytic Increase during Brain Activation, Requiring Glutamate
    Leif Hertz, Ye Chen · 2017 · Frontiers in Integrative Neuroscience
71. Dysfunction of Endoplasmic Reticulum (ER) and Mitochondria (MT) in Alzheimer's Disease: The Role of the ER-MT Cross-Talk
    Katalin Völgyi, Gábor D. Juhász, Zsolt Kovács, Botond Penke · 2015 · Current Alzheimer Research
72. The ire-1 ER Stress-Response Pathway is Required for Normal Secretory- Protein Metabolism in C. elegans
    Modi Safra, Shani Ben-Hamo, Cynthia J. Kenyon, Sivan Henis‐Korenblit · 2013 · Journal of Cell Science
73. Circulating biomarkers of protein oxidation for Alzheimer disease: Expectations within limits
    Fabio Di Domenico, Raffaella Coccia, David Allan Butterfield, Marzia Perluigi A · 2011 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
74. Decreased expression and increased oxidation of plasma haptoglobin in Alzheimer disease: Insights from redox proteomics
    Annalisa Cocciolo, Fabio Di Domenico, Raffaella Coccia, Ada Fiorini, Jian Cai, William M. Jr. Pierce, Patrizia Mecocci, David Allan Butterfield, Marzia Perluigi A · 2012 · Free Radical Biology and Medicine
75. Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease
    Sultana, Rukhsana, Baglioni, Mauro, Cecchetti, Roberta, Cai, Jian, Klein, Jon B., Bastiani, Patrizia, Ruggiero, Carmelinda, Mecocci, Patrizia, Butterfield, D. Allan · 2013 · Free Radical Biology and Medicine
76. Peroxiredoxins in the Central Nervous System
    Fumiyuki Hattori, Shinzo Oikawa · 2007 · Sub-cellular biochemistry/Subcellular biochemistry
77. Senescence‐Accelerated Mouse
    Yasuyuki Nomura, Yojiro Yamanaka, Yoshihisa Kitamura, TAKASHI ARIMA, Toshio Ohnuki, Yutaka Oomura, Kazuo Sasaki, Kazuo Nagashima, Yasuo Ihara · 1996 · Annals of the New York Academy of Sciences
78. Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor proteinΞ
    Renã A. S. Robinson, Miranda L. Bader Lange, Rukhsana Sultana A, Verónica Galván, Joanna Fombonne, Olivia F. Gorostiza, J. Zhang, Govind Warrier, Janet Cai, William M. Jr. Pierce et al. · 2011 · Neuroscience
79. The −48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Aβ load in brain
    Lambert, Jean-Charles, Mann, David M A, Harris, Judith M, Chartier-Harlin, Marie-Christine, Cumming, Alistair, Coates, John, Lemmon, Helen, StClair, David, Iwatsubo, Takeshi, Lendon, Corinne · 2001 · Journal of Medical Genetics
80. Collapsin response mediator protein-2 regulates neurite formation by modulating tubulin GTPase activity
    Young Chan Chae, Sukmook Lee, Kyun Heo · 2009 · Cellular Signalling
81. Landscape of Pin1 in the cell cycle
    Cheng‐Han Lin, Hao‐Yi Li, Yu‐Cheng Lee, Marcus J. Calkins, Kuen‐Haur Lee, Chia-Ning Yang, Pei‐Jung Lu · 2015 · Experimental Biology and Medicine
82. Peroxiredoxins and the Regulation of Cell Death
    Mark B. Hampton, Karina M. O'Connor · 2016 · Molecules and Cells
83. Protective Effect of D609 Against Amyloid-Beta1-42-Induced Oxidative Modification of Neuronal Proteins: Redox Proteomics Study
    Sultana, Rukhsana, Newman, Shelley F., Abdul, Hafiz Mohmmad, Cai, Jian, Pierce, William M., Klein, Jon B., Merchant, Michael, Butterfield, D. Allan · 2006 · Journal of Neuroscience Research
84. Probable Participation of 14-3-3 in Tau Protein Oligomerization and Aggregation
    Nikolai N. Sluchanko, Nikolai B. Gusev · 2011 · Journal of Alzheimer s Disease
85. Processing and Nuclear Localization of CRMP2 during Brain Development Induce Neurite Outgrowth Inhibition
    Véronique Rogemond, Carole Auger, Pascale Giraudon · 2008 · Journal of Biological Chemistry
86. γ‐Glutamylcysteine ethyl ester protection of proteins from Aβ(1–42)‐mediated oxidative stress in neuronal cell culture: A proteomics approach
    Debra Boyd-kimball A, Rukhsana Sultana A, H. Fai Poon, Hafiz Mohmmad Abdul, Bert C. Lynn, Jon B. Klein, David Allan Butterfield · 2005 · Journal of Neuroscience Research
87. Differential Activation of PKC Isozymes by 14-3-3 ζ Protein
    P. Acs, Zoltán Szállási, Marcelo G. Kazanietz · 1995 · Biochemical and Biophysical Research Communications
88. HO-1/BVR-A System Analysis in Plasma from Probable Alzheimer's Disease and Mild Cognitive Impairment Subjects: A Potential Biochemical Marker for the Prediction of the Disease
    Fabio Di Domenico, Eugenio Barone, Cesare Mancuso, Marzia Perluigi A, Annalisa Cocciolo, Patrizia Mecocci, David Allan Butterfield, Raffaella Coccia · 2012 · Journal of Alzheimer s Disease
89. Transgenic Overexpression of 14-3-3 Zeta Protects Hippocampus against Endoplasmic Reticulum Stress and Status Epilepticus In Vivo
    Gary P. Brennan, Eva Maria Jimenez-Mateos, Ross C. McKiernan, Tobías Engel, Guri Tzivion, David Clifford Henshall · 2013 · PLoS ONE
90. The alternative role of 14-3-3 zeta as a sweeper of misfolded proteins in disease conditions
    Kiyotoshi Kaneko, Naomi Hachiya · 2006 · Medical Hypotheses
91. Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: A proteomics study
    Ada Fiorini, Rukhsana Sultana A, Sarah Förster, Marzia Perluigi A, Giovanna Cenini, Chiara Cini, Jian Cai, Jon B. Klein, Susan A. Farr, Michael L. Niehoff et al. · 2013 · Free Radical Biology and Medicine
92. Redox Proteomics: A Key Tool for New Insights into Protein Modification with Relevance to Disease
    David Allan Butterfield, Marzia Perluigi A · 2016 · Antioxidants and Redox Signaling
93. Increase in Presenilin 1 (PS1) levels in senescence-accelerated mice(SAMP8) may indirectly impair memory by affecting amyloid precursor protein(APP) processing
    Vijaya B. Kumar, Mark W. Franko, William A. Banks, Pranav Kasinadhuni, Susan A. Farr, Kamlesh Vyas, Veena Choudhuri, John Edward Morley · 2009 · Journal of Experimental Biology
94. Early‐onset Alzheimer's disease: An analysis of CT findings
    Burton P. Drayer, Albert Heyman, William E. Wilkinson · 1985 · Annals of Neurology
95. Proteomic identification of specifically carbonylated brain proteins in APPNLh/APPNLh×PS-1P264L/PS-1P264L human double mutant knock-in mice model of Alzheimer disease as a function of age
    Sultana, Rukhsana, Robinson, Renã A.S., Di Domenico, Fabio, Abdul, Hafiz Mohmmad, Clair, Daret K.St., Markesbery, William R., Cai, Jian, Pierce, William M., Butterfield, D. Allan · 2011 · Journal of Proteomics
96. Age-related loss of phospholipid asymmetry in APP /APP x PS-1 /PS-1 human double mutant knock-in mice: Relevance to Alzheimer disease
    Miranda L. Bader Lange, Daret K. St. Clair, William R. Markesbery, Christa M. Studzinski, Michael Paul Murphy, David Allan Butterfield · 2010 · Neurobiology of Disease
97. The Significance of Pin1 in the Development of Alzheimer's Disease
    Suqing Wang, B. Simon, David Alan Bennett, Julie A. Schneider, James S. Malter, Deng-Shun Wang · 2007 · Journal of Alzheimer s Disease
98. Depletion of 14‐3‐3 zeta elicits endoplasmic reticulum stress and cell death, and increases vulnerability to kainate‐induced injury in mouse hippocampal cultures
    Niamh Murphy, Helena P. Bonner, Manus W. Ward · 2008 · Journal of Neurochemistry
99. Fronto-temporal-lobe atrophy in early-stage Alzheimer's disease identified using an improved detection methodology
    Tom F.D. Farrow, Subha N. Thiyagesh, Iain David Wilkinson, Randolph W. Parks, Leanne Ingram, Peter W R Woodruff · 2007 · Psychiatry Research Neuroimaging
100. Proteomic approaches to quantify cysteine reversible modifications in aging and neurodegenerative diseases
     Liqing Gu, Renã A. S. Robinson · 2016 · PROTEOMICS - CLINICAL APPLICATIONS
101. Decreased Brain Glucose Metabolism in Microvessels from Patients with Alzheimer's Diseasea
     David L. Marcus, Michael L. Freedman · 1997 · Annals of the New York Academy of Sciences
102. Identification of the oxidative stress proteome in the brain
     Rukhsana Sultana A, David Allan Butterfield · 2010 · Free Radical Biology and Medicine
103. The redox switch that regulates molecular chaperones
     Myra E. Conway, Christopher Lee · 2015 · BioMolecular Concepts
104. Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer’s Disease
     Lingyan Xu, Zhiyun Ren, Frances Elaine Chow, Richard Tsai, Tongzheng Liu, Flavio Rizzolio, Silvia Boffo, Yungen Xu, Shaohui Huang, Carol Frances Lippa et al. · 2017 · Neural Plasticity
105. Proteomics Identification of Carbonylated and HNE-Bound Brain Proteins in Alzheimer’s Disease
     Rukhsana Sultana A, David Allan Butterfield · 2009 · Methods in molecular biology
106. The identification of protein biomarkers for oxidative stress in Down syndrome
     Marzia Perluigi A, David Allan Butterfield · 2011 · Expert Review of Proteomics
107. In Vitro and in vivo Protein Oxidation Induced by Alzheimer's Disease Amyloid β‐Peptide (1–42)
     David Allan Butterfield, Servet M. Yatin, Christopher D. Link · 1999 · Annals of the New York Academy of Sciences
108. Canaries in a Coal Mine
     Brent J. Small, Laura Fratiglioni, Lars Bäckman · 2001 · Archives of General Psychiatry
109. 14-3-3ζ Mediates Tau Aggregation in Human Neuroblastoma M17 Cells
     Tong Li, Hemant K. Paudel · 2016 · PLoS ONE
110. The 14-3-3ζ Protein Binds to the Cell Adhesion Molecule L1, Promotes L1 Phosphorylation by CKII and Influences L1-Dependent Neurite Outgrowth
     Elisa M. Ramser, Gerrit Wolters‐Eisfeld, Alexander E. Dityatev · 2010 · PLoS ONE
111. Proteomic analysis of 14-3-3 zeta binding proteins in the mouse hippocampus
     Maura Heverin, Gary P. Brennan, Christian Jeffrey Koehler · 2012 · PubMed
112. Hippocampal Cholinergic Neurostimulating Peptide as a Possible Modulating Factor against Glutamatergic Neuronal Disability by Amyloid Oligomers
     Toyohiro Sato, Yoshiaki Ohi, Daisuke Kato, Masayuki Mizuno, Hiroshi Takase, Tetsuko Kanamori, Cesar V. Borlongan, Akira Haji, Noriyuki Matsukawa · 2017 · Cell Transplantation
113. Structure‐oriented review of 14‐3‐3 protein isoforms in geriatric neuroscience
     Takahiko Umahara, Toshiki Uchihara, Toshihiko Iwamoto · 2012 · Geriatrics and gerontology international/Geriatrics & gerontology international
114. Co-localization of hippocampal cholinergic neurostimulating peptide precursor with collapsin response mediator protein-2 at presynaptic terminals in hippocampus
     Daisuke Kato, Shigehisa Mitake, Masayuki Mizuno · 2012 · Neuroscience Letters
115. Redox Proteomics in Human Biofluids: Sample Preparation, Separation and Immunochemical Tagging for Analysis of Protein Oxidation
     Fabio Di Domenico, Marzia Perluigi, David Allan Butterfield · 2015 · Methods in molecular biology